This is literally how developers use AI now: battle of the models.

Anthropic is so back. Two things I like the most about Claude-3's release: 1. Domain expert benchmarks. I'm much less interested in the saturated MMLU & HumanEval. Claude specifically picks Finance, Medicine, and Philosophy as expert domains and report performance. I recommend all LLM model cards to follow this, so that the different downstream applications know what to expect. 2. Refusal rate analysis. LLMs' overly cautious answers to innocent questions are becoming a pandemic. Anthropic is typically on the ultra safe end of the spectrum, but they recognize the problem and highlight their efforts on it. Bravo! I love that Claude dials up heat in the arena that GPT and Gemini dominate. Though keep in mind that GPT-4V, the high water mark that everyone desperately tries to beat, finished training in 2022. It's the calm before the storm.

Artificial intelligence (#AI) and machine learning (ML) continue to push the boundaries of what is possible in marketing and sales. Now, generative AI promises to disrupt the way B2B and B2C players think about customer experience, and growth. Learn more: mck.co/45Jwcwu

20y ago Discovery of PCSK9 genetics by Abifadel, Seidah, and Boileau Mutations cause genetic high LDL cholesterol (familial hypercholesterolemia), subsequently established to be gain-of-function *2y later, loss-of-function mutations = low LDL-C & resistance to heart attack

Novartis researchers have shared the Secondary Pharmacology Database, a new resource that elucidates associations between drug bioactivity and potential adverse drug reactions (ADRs). Thank you, team, for this useful tool! nature.com/articles/s41467-0…

😲 Time to revise textbooks 🤔 Title: "Transcription factors interact with RNA to regulate genes" "at least half of TFs also bind RNA, doing so through a previously unrecognized domain" cell.com/molecular-cell/pdf/…

Applications of Transformers New survey paper highlighting major applications of Transformers for deep learning tasks. Includes a comprehensive list of Transformer models. arxiv.org/abs/2306.07303

On today's Cross Validated podcast, we have Kim Branson, Senior Vice President and Global Head of AI and ML at GSK. GSK is one of the 10 largest pharmaceutical companies globally. @altcap In this episode, we discuss: - Applying ML to genetic data, clinical trials and more + gen AI to processes - Building on open source technologies and reusable components in models - Data and data generation as a critical asset - Regulatory framework on AI Subscribe for the next episode: t.ly/6imFA

ISM3091, Insilico's novel synthetic lethality inhibitor targeting USP1, receives FDA IND approval. Designed by AI, it has shown +results in preclinical trials across multiple tumor cell lines and in vivo models & could tackle resistance to PARP inhibitors. lnkd.in/gBZzgP3t

With Windows Copilot, every Windows user can be a power user. blogs.windows.com/windowsdev…